Showing results (1141-1150 of 3,868) with videos related to
Sort By:
Pageof 387
Cancer Biology & Therapy|June 9, 2006
9-cis retinoic acid induces insulin-like growth factor binding protein-3 through DR-8 retinoic acid responsive elementsYoon Soo Chang, Jae Yong Cho, Hyun A Cho, et al.Cancer Biology & Therapy|June 9, 2006
Kit-activating mutations in AML: lessons from PU.1-induced murine erythroleukemiaDiana Cozma, Andrei Thomas-TikhonenkoCancer Biology & Therapy|June 9, 2006
Stable knockdown of estrogen receptor alpha by vector-based RNA interference suppresses proliferation and enhances apoptosis in breast cancer cellsHai-Jing Fu, Lin-Tao Jia, Wei Bao, et al.Cancer Biology & Therapy|June 9, 2006
Activation of ATM and histone H2AX phosphorylation induced by mitoxantrone but not by topotecan is prevented by the antioxidant N-acetyl-L-cysteineXuan Huang, Akira Kurose, Toshiki Tanaka, et al.Cancer Biology & Therapy|September 14, 2006
Managing bone complications of solid tumorsJames R Berenson, Lakshmi Rajdev, Michael BroderCancer Biology & Therapy|August 25, 2006
Preferential involvement of CX chemokine receptor 4 and CX chemokine ligand 12 in T-cell migration toward melanoma cellsTianqian Zhang, Rajasekharan Somasundaram, Carola Berking, et al.Cancer Biology & Therapy|September 14, 2006
Circulating cell-free DNA: a novel biomarker for response to therapy in ovarian carcinomaAparna A Kamat, Farideh Z Bischoff, Dianne Dang, et al.Cancer Biology & Therapy|September 14, 2006
Recurrent KRAS codon 146 mutations in human colorectal cancerSarah Edkins, Sarah O'Meara, Adrian Parker, et al.Cancer Biology & Therapy|September 14, 2006
Mcl-1 is a relevant molecular target for antisense oligonucleotide strategies in gastric cancer cellsVolker Wacheck, Daniel Cejka, Wolfgang Sieghart, et al.Cancer Biology & Therapy|September 14, 2006
Lysyl oxidase (LOX) and hypoxia-induced metastasesAmy M Sion, William D FiggPageof 387